CGTX CIK: 1455365

Cognition Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.6
FY22:
−43.6
FY23:
−50.7
FY24:
−54.0
FY25:
−47.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.7
FY22:
−21.4
FY23:
−25.8
FY24:
−34.0
FY25:
−23.5

All amounts in millions USD Data source:SEC EDGAR